Pharma

Venture capitalists in US remain bullish on medical devices, health IT

Venture investments held strong and steady across healthcare in 2011, with medical devices finishing a close second to biopharmaceuticals in dollars invested and healthcare IT seeing a substantial increase over the previous year. According to a report from Dow Jones, investors poured $8.4 billion into 738 deals for healthcare companies—down only a little from 2010, when the industry drew $8.3 billion for 747 deals.

dIgitalhealth

Biopharmaceuticals brought in $3.9 billion for 302 deals while 290 medical device deals raised $3.3 billion. An interesting aside popped up in 2011s third quarter, when devices bested drugs for the first time since 1998.

Finishing third within healthcare was IT, which corralled $633 million for 86 deals. Dow Jones VentureSource cited the strength of interest in EMRs, internet and mobile applications, and information management tools. The numbers represented a 26 percent increase in deal activity and a 22 percent increase in capital raised over the previous year for healthcare IT.

dIgitalhealth

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

SUBSCRIBE OUR NEWSLETTER
200000+ Subscribers read it every day.
Subscribe Newsletter
To Top